PSORIASIS

Novel psoriasis drugs show high clearance rates

International report — Two experimental psoriasis drugs that target the interleukin(IL)-17 signaling pathway led to significant improvements in skin lesions for a majority patients over 12 weeks, separate phase 2 studies show. The majority of patients receiving one of the drugs at a higher dose showed total clearance. » More

PUVA treatments increase risk of SCC

Cambridge, Mass. — The long-term risk of squamous cell carcinoma (SCC) is significantly higher for patients with severe psoriasis who receive more than 350 psoralen and ultraviolet A (PUVA) treatments compared with those who receive fewer than 50 treatments, a new study shows. » More

Resource Center: Eczema: Emollients, Counseling, and Care

Folic Acid Supplements Up Risk of Eczema.

FYI ...

7.5 million

Number of U.S. residents living with psoriasis

Source: American Academy of Dermatology

Customize Automated Messaging via phone, text and email

PhoneTree HealthWave messaging solutions provide an efficient and cost-effective method to communicate with your patients. Both hosted and hardware solutions available. No hidden fees. Satisfaction Guaranteed. www.phonetree.com

ACNE

Thyme proves promising in treating acne

Leeds, England — A British study suggests that herbal preparations of thyme may be more effective in treating skin acne than prescription creams. » More

ECZEMA

Study: Most kids have allergy-related diseases

Stockholm — A just-published Swedish study states that a majority of children have one or more allergy-related conditions, including eczema, asthma and rhinitis. » More

New Job Opportunities

Andrew Kornstein MD		Chattanooga Skin & Cancer Center
Cynthia Dreyer MD		Dr. Ira Schlesinger
David A High MD		Dermatology Associates of Lancaster
Lakawanna Valley Dermatology		Madison Skin & Laser
Manhattan Dermatology		Mark Burnett
Siperstein Dermatology

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Dermatology Times please take a moment to confirm your subscription by clicking here.
Thank you,
Dermatology Times Staff

Tools

•	Information Technology
•	Meetings & Events
•	Practice Management
•	Resource Centers

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.